BRPI0705564B8 - continuous liquid crystal type system containing co-solvents carrying sparingly soluble substances in water, its process of obtaining and its uses - Google Patents
continuous liquid crystal type system containing co-solvents carrying sparingly soluble substances in water, its process of obtaining and its usesInfo
- Publication number
- BRPI0705564B8 BRPI0705564B8 BRPI0705564A BRPI0705564A BRPI0705564B8 BR PI0705564 B8 BRPI0705564 B8 BR PI0705564B8 BR PI0705564 A BRPI0705564 A BR PI0705564A BR PI0705564 A BRPI0705564 A BR PI0705564A BR PI0705564 B8 BRPI0705564 B8 BR PI0705564B8
- Authority
- BR
- Brazil
- Prior art keywords
- soluble substances
- obtaining
- water
- liquid crystal
- poorly water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
Landscapes
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Agronomy & Crop Science (AREA)
- Dispersion Chemistry (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Abstract
sistema portador de substâncias fracamente solúveis em água, processo para sua obtenção e seus usos a presente invenção se refere a um sistema portador de substâncias fracamente solúveis em água compreendendo (i) um composto lipídico, (ii) um co-solvente e (iii) água, dito sistema sendo um líquido constituído de fase liotrópica em equilíbrio termodinâmico, na forma de fase l3 (fase esponja), obtida a partir de proporções estequiometricamente definidas. a invenção também contempla um processo para a obtenção de dito sistema portador de substâncias fracamente solúveis em água, bem como o seu uso como meio portador de substâncias fracamente solúveis em água, tais como fármacos, pesticidas, herbicidas, proteínas, aminoácidos, vitaminas, antibióticos e substâncias semelhantes para a preparação de composições ou para o recobrimento de nanopartículas.system carrier of poorly water-soluble substances, process for obtaining them and their uses the present invention relates to a carrier system of poorly water-soluble substances comprising (i) a lipid compound, (ii) a co-solvent and (iii) water, said system being a liquid consisting of a lyotropic phase in thermodynamic equilibrium, in the form of phase l3 (sponge phase), obtained from stereochemically defined proportions. the invention also contemplates a process for obtaining said system carrying poorly water-soluble substances, as well as its use as a carrier medium for poorly water-soluble substances, such as drugs, pesticides, herbicides, proteins, amino acids, vitamins, antibiotics and similar substances for preparing compositions or for coating nanoparticles.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0705564A BRPI0705564B8 (en) | 2007-10-10 | 2007-10-10 | continuous liquid crystal type system containing co-solvents carrying sparingly soluble substances in water, its process of obtaining and its uses |
PCT/BR2008/000305 WO2009046511A2 (en) | 2007-10-10 | 2008-08-10 | Carrier system for weakly water soluble substances, process for obtaining said system and its uses |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0705564A BRPI0705564B8 (en) | 2007-10-10 | 2007-10-10 | continuous liquid crystal type system containing co-solvents carrying sparingly soluble substances in water, its process of obtaining and its uses |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0705564A2 BRPI0705564A2 (en) | 2009-06-16 |
BRPI0705564B1 BRPI0705564B1 (en) | 2020-09-15 |
BRPI0705564B8 true BRPI0705564B8 (en) | 2021-05-25 |
Family
ID=40549635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0705564A BRPI0705564B8 (en) | 2007-10-10 | 2007-10-10 | continuous liquid crystal type system containing co-solvents carrying sparingly soluble substances in water, its process of obtaining and its uses |
Country Status (2)
Country | Link |
---|---|
BR (1) | BRPI0705564B8 (en) |
WO (1) | WO2009046511A2 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0148748B1 (en) * | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | A multiphase cyclosporin composition |
US5510118A (en) * | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
AU1928501A (en) * | 1999-11-24 | 2001-06-04 | Sugen, Inc. | Formulations for pharmaceutical agents ionizable as free acids or free bases |
AR038628A1 (en) * | 2002-03-04 | 2005-01-19 | Novartis Ag | OPHTHALM COMPOSITION |
CA2528095C (en) * | 2003-06-04 | 2014-10-14 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof |
-
2007
- 2007-10-10 BR BRPI0705564A patent/BRPI0705564B8/en active IP Right Grant
-
2008
- 2008-08-10 WO PCT/BR2008/000305 patent/WO2009046511A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009046511A2 (en) | 2009-04-16 |
BRPI0705564B1 (en) | 2020-09-15 |
BRPI0705564A2 (en) | 2009-06-16 |
WO2009046511A3 (en) | 2010-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2007003187A1 (en) | COMPOUNDS DERIVED FROM BENCIL-BENZONITRILE SUBSTITUTED WITH GLUCOPIRANOSIL AND ITS SALTS; PREPARATION PROCEDURE; INTERMEDIARY COMPOUNDS; PROCESS TO PREPARE INTERMEDIATE COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF | |
AR064220A1 (en) | MAB ABETA LIOFILIZED FORMULATION | |
Xu et al. | Peptide hydrogel with antibacterial performance induced by rare earth metal ions | |
CO6290656A2 (en) | UREA HETEROCICLICAL DERIVATIVES AND METHODS OF USE OF THE SAME -211 | |
AR061024A1 (en) | MALEATE OF 5-AMINO-3- (2'3'-DI-O-ACETYL-BETA-D-RIBOFURANOSIL) -3H-TIAZOLO [4,5-D] PYRIMIDIN-2-ONA. | |
UY32158A (en) | HETEROCICLIC DERIVATIVES AND METHODS OF USE OF THE SAME | |
UY31277A1 (en) | NEW DERIVATIVES OF 6-TRIAZOLOPIRIDACINA -SULFANIL BENZOTIAZOL AND BENCIMIDAZOL, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICATIONS, PHARMACEUTICAL COMPOSITIONS AND NEW MAIN USE AS MET INHIBITORS | |
UY32203A (en) | AMINO PIRIMIDINAS AND ITS USE IN THERAPY | |
PA8800701A1 (en) | MALEATE SALTS OF [E] -N- {4- [3-CHLORO-4- [2-PIRIDINYLMETOXI] ANILINO] -3-CIANO-7-ETOXI-6-QUINOLINIL} -4- [DIMETHYLAMINE] -2-BUTENAMIDE , ITS CRYSTAL FORMS, PROCESSES FOR THEIR PREPARATION, AND METHODS FOR USE | |
BR112013002125A2 (en) | c-aryl glycoside derivatives, their uses and their preparation process as well as pharmaceutical composition | |
MA32565B1 (en) | NOVEL IMIDAZO [1,2-a] PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS MET INHIBITORS | |
MA32570B1 (en) | NOVEL TRIAZOLO (4,3-a) PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS MET INHIBITORS | |
Lara et al. | PKA-mediated effect of MAS receptor in counteracting angiotensin II-stimulated renal Na+-ATPase | |
SV2011003811A (en) | NEW IMIDAZO DERIVATIVES [1,2-A] PYRIMIDINE, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND NEW USE IN PARTICULARLY AS MET INHIBITORS | |
CO6351722A2 (en) | UREA HETEROCICLICAL DERIVATIVES AND THEIR EMPLOYMENT METHODS | |
BR112013018616A2 (en) | solvent-based adhesive containing chlorhexidine gluconate | |
UY32856A (en) | UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME | |
UY32674A (en) | UREA HETEROCICLICAL DERIVATIVES AND THEIR EMPLOYMENT METHODS | |
BR112015001207A8 (en) | carbamate / urea derivatives, their uses, pharmaceutical composition, free form and their method of preparation | |
CL2008000573A1 (en) | CRYSTAL FORM OF SALT 3-ENDO- (8- [2- [CYCLHEXILMETILE - ((S) -2,3-DIHYDROXY-PROPIONYL) AMINO] ETIL] -8AZA-BICYCLE [3,2,1] OCT-3- IL) BENZAMIDE; PROCESS FOR THE PREPARATION OF SUCH SALT; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH SALT; AND ITS USE IN DISFU | |
UY32694A (en) | UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME | |
EA201492186A1 (en) | CONTAINING ANTIBODIES TO Dll4 STABILIZED COMPOSITIONS | |
BRPI0705564B8 (en) | continuous liquid crystal type system containing co-solvents carrying sparingly soluble substances in water, its process of obtaining and its uses | |
UY32422A (en) | DERIVATIVES OF 6- (6-SUBSTITUTED-TRIAZLOPIRIDACINA-SULFANIL) 5-FLUORO-BENZOTIAZOLOLES AND 5-FLUORO-BENCIMIDAZOLS: PREPARATION, APPLICATION AS MEDICATIONS AND USE AS MET INHIBITORS | |
PE20130064A1 (en) | A PHARMACEUTICAL COMPOSITION SOLUBLE IN WATER INCLUDING AT LEAST ONE THERAPEUTICALLY ACTIVE SUBSTANCE WITH HYDROPHOBIC CHARACTERISTICS AND AT LEAST ONE COMPOUND SELECTED AMONG THE SIALOGLYCOSPHINGOLIPIDES, LOSICOESPHINGOLIPLIDOS GLYZOS, AND A SIEMOSPHINGOLIPLIPIDES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE 5A. ANUIDADE(S). |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE A DESPACHO 8.6 NA RPI 2217 DE 02/07/2013. |
|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE 6A. ANUIDADE(S). |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2229 DE 24/09/2013 |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/09/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/10/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |